Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naroa Serna

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Small (Weinheim an Der Bergstrasse, Germany)|May 31, 2018
Selective CXCR4<sup>+</sup> Cancer Cell Targeting and Potent Antineoplastic Effect by a Nanostructured Version of Recombinant RicinRaquel Díaz, Victor Pallarès, Olivia Cano-Garrido, et al.
Acta Pharmaceutica Sinica. B|June 1, 2022
Self-assembling protein nanocarrier for selective delivery of cytotoxic polypeptides to CXCR4<sup>+</sup> head and neck squamous cell carcinoma tumorsElisa Rioja-Blanco, Irene Arroyo-Solera, Patricia Álamo, et al.
Cancers|July 2, 2021
Biparatopic Protein Nanoparticles for the Precision Therapy of CXCR4<sup>+</sup> CancersOlivia Cano-Garrido, Patricia Álamo, Laura Sánchez-García, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 5, 2022
CXCR4-targeted nanotoxins induce GSDME-dependent pyroptosis in head and neck squamous cell carcinomaElisa Rioja-Blanco, Irene Arroyo-Solera, Patricia Álamo, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 20, 2022
Engineering non-antibody human proteins as efficient scaffolds for selective, receptor-targeted drug deliveryNaroa Serna, Victor Pallarès, Ugutz Unzueta, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 14, 2022
A diphtheria toxin-based nanoparticle achieves specific cytotoxic effect on CXCR4<sup>+</sup> lymphoma cells without toxicity in immunocompromised and immunocompetent miceAïda Falgàs, Annabel Garcia-León, Yáiza Núñez, et al.
ACS Applied Materials & Interfaces|December 17, 2019
Engineering a Nanostructured Nucleolin-Binding Peptide for Intracellular Drug Delivery in Triple-Negative Breast Cancer Stem CellsMireia Pesarrodona, Laura Sánchez-García, Joaquin Seras-Franzoso, et al.
Pharmaceutics|October 27, 2020
Fluorescent Dye Labeling Changes the Biodistribution of Tumor-Targeted NanoparticlesPatricia Álamo, Victor Pallarès, María Virtudes Céspedes, et al.
Biomaterials|November 30, 2021
A multivalent Ara-C-prodrug nanoconjugate achieves selective ablation of leukemic cells in an acute myeloid leukemia mouse modelVictor Pallarès, Ugutz Unzueta, Aïda Falgàs, et al.
Acta Biomaterialia|June 11, 2021
Rational engineering of a human GFP-like protein scaffold for humanized targeted nanomedicinesPatricia Álamo, Juan Cedano, Oscar Conchillo-Sole, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Small (Weinheim an Der Bergstrasse, Germany)|May 31, 2018
Selective CXCR4<sup>+</sup> Cancer Cell Targeting and Potent Antineoplastic Effect by a Nanostructured Version of Recombinant RicinRaquel Díaz, Victor Pallarès, Olivia Cano-Garrido, et al.
Acta Pharmaceutica Sinica. B|June 1, 2022
Self-assembling protein nanocarrier for selective delivery of cytotoxic polypeptides to CXCR4<sup>+</sup> head and neck squamous cell carcinoma tumorsElisa Rioja-Blanco, Irene Arroyo-Solera, Patricia Álamo, et al.
Cancers|July 2, 2021
Biparatopic Protein Nanoparticles for the Precision Therapy of CXCR4<sup>+</sup> CancersOlivia Cano-Garrido, Patricia Álamo, Laura Sánchez-García, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 5, 2022
CXCR4-targeted nanotoxins induce GSDME-dependent pyroptosis in head and neck squamous cell carcinomaElisa Rioja-Blanco, Irene Arroyo-Solera, Patricia Álamo, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 20, 2022
Engineering non-antibody human proteins as efficient scaffolds for selective, receptor-targeted drug deliveryNaroa Serna, Victor Pallarès, Ugutz Unzueta, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 14, 2022
A diphtheria toxin-based nanoparticle achieves specific cytotoxic effect on CXCR4<sup>+</sup> lymphoma cells without toxicity in immunocompromised and immunocompetent miceAïda Falgàs, Annabel Garcia-León, Yáiza Núñez, et al.
ACS Applied Materials & Interfaces|December 17, 2019
Engineering a Nanostructured Nucleolin-Binding Peptide for Intracellular Drug Delivery in Triple-Negative Breast Cancer Stem CellsMireia Pesarrodona, Laura Sánchez-García, Joaquin Seras-Franzoso, et al.
Pharmaceutics|October 27, 2020
Fluorescent Dye Labeling Changes the Biodistribution of Tumor-Targeted NanoparticlesPatricia Álamo, Victor Pallarès, María Virtudes Céspedes, et al.
Biomaterials|November 30, 2021
A multivalent Ara-C-prodrug nanoconjugate achieves selective ablation of leukemic cells in an acute myeloid leukemia mouse modelVictor Pallarès, Ugutz Unzueta, Aïda Falgàs, et al.
Acta Biomaterialia|June 11, 2021
Rational engineering of a human GFP-like protein scaffold for humanized targeted nanomedicinesPatricia Álamo, Juan Cedano, Oscar Conchillo-Sole, et al.
Pageof 6